1. Pink Sheet
  2. >>Market Access

FDA To Issue Decision On Florida’s Drug Importation Proposal By October

 
• By Brenda Sandburg

Florida was the first of four states to submit proposals for importation of prescription drugs from Canada. PhRMA recently filed a citizen petition opposing Colorado’s proposal, which notes hurdles it is facing. Infographic compares state proposals and the drugs they plan to import.

Drug importation
FDA is moving to complete reivew of Florida's proposed program to import prescription drugs from Canada • Source: Shutterstock

The US Food and Drug Administration might be close to authorizing the first state program to import prescription drugs from Canada. The agency noted in a recent court filing that it is reviewing Florida’s amended program proposal and will be issuing a decision by 31 October.

Key Takeaways

  • FDA could authorize the first two prescription drug importation proposals, from Florida and Colorado, this year.

The agency's acceptance of the proposal would be a significant event, following years of debate over whether prescription drug importation...

More from Market Access

More from Pink Sheet

Recent And Upcoming FDA Advisory Committee Meetings

 
• By Sue Sutter

Recent and upcoming US FDA advisory committee meetings and a summary of the topics covered.

UK-Wide Strategy Needed To Move Clinical Trial Diversity Plans To Next Stage

 
• By Vibha Sharma

The UK’s research-based pharma industry and medical research charities have set out clear action points to drive greater diversity and inclusion in clinical trials.

Blenrep’s Comeback Continues As England Becomes First To Fund Drug

 
• By Eliza Slawther

Blenrep, GSK’s multiple myeloma therapy, faced a major setback when it was withdrawn from the market in 2022. The drug has since made a return as a second-line therapy, and is on track to being reimbursed in England.